Abstract Exosomes are nanosized (size~ 30–150 nm) natural vesicular structures released
from cells by physiological processes or pathological circumstances. Exosomes are growing …

In order to improve bioavailability, stability, control release, and target delivery of active
pharmaceutical ingredients (APIs), as well as to mask their bitter taste, to increase their …

Immune checkpoint blockade (ICB) therapy for cancer has achieved great success both in
clinical results and on the market. At the same time, success drives more attention from …

Over the past several decades, liposomes have been extensively developed and used for
various clinical applications such as in pharmaceutical, cosmetic, and dietetic fields, due to …

Biomimetic delivery systems (BDSs), inspired by the intricate designs of biological systems,
have emerged as a groundbreaking paradigm in nanomedicine, offering unparalleled …

Lipid-based nanocarriers have been extensively investigated for their application in drug
delivery. Particularly, liposomes are now clinically established for treating various diseases …

Biofilm-related diseases are a group of diseases that tolerate antimicrobial chemotherapies
and therefore are refractory to treatment. Periodontitis, a non-device chronic biofilm disease …

Because the feeding of our body through the oral route can be associated with many
drawbacks due to the degradation of natural molecules during transit in the gastrointestinal …

The increasing worldwide cancer prevalence is a result of population aging and expansion
and changes in individuals' exposure to risk factors, many of which are linked to …

Introduction Exosomes, a type of extracellular vesicles, are effective tools for delivering small-
molecule drugs and biological therapeutics into cells and tissues. Surface modifications with …